Clinical Trials Browser

Phase 2 × Breast Neoplasms × allantoicase × Clear all

NCT00555841 2012-08-28

Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue

Phase 2 Terminated

Breast Neoplasms